# Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination

> **NCT05157425** · NA · COMPLETED · sponsor: **AB Biotics, SA** · enrollment: 140 (actual)

## Conditions studied

- Influenza Vaccine

## Interventions

- **DIETARY_SUPPLEMENT:** Food Supplement
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05157425
- **Lead sponsor:** AB Biotics, SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-26
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-05-31
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2022-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05157425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05157425, "Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05157425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*